Consistent with these findings, TFEB levels were also found to be reduced in both Huntington's disease cell and mouse models [41], implying that reduced expression of TFEB is a key element in the pathogenesis of not only AD and ALS but also other neurodegenerative diseases. The gene discussed is TFEB; the disease is juvenile Huntington disease.